Skip to main navigation menu Skip to main content Skip to site footer

Information For Authors

Aims and scope

The International Journal of Clinical Medicine and Pharmacology (IJCMP) publishes original contributions that span a wide range of topics, including but not limited to:

  • Ethics and Society​: Ethical considerations, cultural factors, and social determinants of health impacting clinical practices.
  • Clinical Medicine​: Advances in diagnostics, therapeutics, and patient care across specialties such as oncology, cardiology, pediatrics, and mental health.
  • Pharmacology​: Drug development, pharmacokinetics, pharmacodynamics, and safety monitoring.
  • Public Health​: Epidemiology, health policy, health equity, and strategies for improving access to healthcare.
  • Biomedical Sciences​: Innovations in imaging, genetics, artificial intelligence, and emerging medical technologies.
Article types

Translated articles originally published in a language other than English will not be considered.

  • Full-Length Research Articles
  • Review Articles (4,000–8,000 words): Critical overviews and syntheses of literature in clinical medicine and pharmacology.
  • Case Studies (4,000-6,000 words): Analysis of unique or illustrative clinical cases highlighting innovative approaches.
  • Viewpoints (1,500-2,000 words): Short articles presenting commentary or proposing new ideas.
  • Special Issue Proposals
Peer review

At the IJCMP, we uphold rigorous academic standards through a double-anonymous peer review process, ensuring that both authors and reviewers remain anonymous throughout the review to maintain fairness and objectivity.

This journal follows a double anonymized review process which means author identities are concealed from reviewers and vice versa. To facilitate the double anonymized review process, we ask that you provide your title page (including author details) and anonymized manuscript (excluding author details) separately in your submission.

The title page should include:

  • Article title
  • Author name(s)
  • Affiliation(s)
  • Acknowledgements
  • Declaration of Interest statement
  • Corresponding author address (full address is required)
  • Corresponding author email address

The anonymized manuscript should contain the main body of your paper including:

  • References
  • Figures
  • Tables

It is important that your anonymized manuscript does not contain any identifying information such as author names or affiliations.

Open access

The IJCMP is committed to promoting the widest possible dissemination of research by providing immediate and unrestricted access to all published content. As an open-access journal, we adhere to the following principles:

Unrestricted Access
  • All content published in JSBE is freely accessible online without charge to the user or their institution.
  • Users are permitted to:
    • Read, download, copy, distribute, print, search, or link to the full texts of the articles.
    • Use the content for any other lawful purposes without requiring prior permission from the publisher or the author.
Licensing and Copyright
  • Articles are published under the CC BY 4.0 license, allowing unrestricted reuse and adaptation of the content, provided appropriate credit is given to the original authors and the source.
Benefits of Open Access
  • Authors retain copyright to their work and benefit from increased visibility, impact, and citation of their research.
  • Readers and researchers worldwide gain free access to high-quality, peer-reviewed content without financial or technical restrictions.
Ethics and policies

The IJCMP is committed to upholding the highest standards of integrity and transparency in scholarly publishing. Our publication ethics are guided by the principles established by the Committee on Publication Ethics (COPE) and reflect our dedication to fostering an ethical and responsible academic community.

Authorship

All authors should have made substantial contributions to all of the following:

  1. The conception and design of the study, or acquisition of data, or analysis and interpretation of data.
  2. Drafting the article or revising it critically for important intellectual content.
  3. Final approval of the version to be submitted.

Authors should appoint a corresponding author to communicate with the journal during the editorial process. All authors should agree to be accountable for all aspects of the work to ensure that the questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Changes to authorship

The editors of this journal generally will not consider changes to authorship once a manuscript has been submitted. It is important that authors carefully consider the authorship list and order of authors and provide a definitive author list at original submission.

The policy of this journal around authorship changes:

  • All authors must be listed in the manuscript and their details entered into the submission system.
  • Any addition, deletion or rearrangement of author names in the authorship list should only be made prior to acceptance, and only if approved by the journal editor.
  • Requests to change authorship should be made by the corresponding author, who must provide the reason for the request to the journal editor with written confirmation from all authors, including any authors being added or removed, that they agree with the addition, removal or rearrangement.
  • All requests to change authorship must be submitted using this form. Requests which do not comply with the instructions outlined in the form will not be considered.
  • Only in exceptional circumstances will the journal editor consider the addition, deletion or rearrangement of authors post acceptance.
  • Publication of the manuscript may be paused while a change in authorship request is being considered.
  • Any authorship change requests approved by the journal editor will result in a corrigendum if the manuscript has already been published.
  • Any unauthorised authorship changes may result in the rejection of the article, or retraction, if the article has already been published.
Declaration of interests

All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:

  • Employment
  • Consultancies
  • Stock ownership
  • Honoraria
  • Paid expert testimony
  • Patent applications or registrations
  • Grants or any other funding

Authors with no competing interests to declare should select the option, “I have nothing to declare”.

The resulting Word document containing your declaration should be uploaded at the “attach/upload files” step in the submission process. It is important that the Word document is saved in the .doc/.docx file format. Author signatures are not required.

Declaration of generative AI in scientific writing

Authors must declare the use of generative AI in scientific writing upon submission of the paper. The following guidance refers only to the writing process, and not to the use of AI tools to analyse and draw insights from data as part of the research process:

  • Generative AI and AI-assisted technologies should only be used in the writing process to improve the readability and language of the manuscript.
  • The technology must be applied with human oversight and control and authors should carefully review and edit the result, as AI can generate authoritative-sounding output that can be incorrect, incomplete or biased. Authors are ultimately responsible and accountable for the contents of the work.
  • Authors must not list or cite AI and AI-assisted technologies as an author or co-author on the manuscript since authorship implies responsibilities and tasks that can only be attributed to and performed by humans.

The use of generative AI and AI-assisted technologies in scientific writing must be declared by adding a statement at the end of the manuscript when the paper is first submitted. The statement will appear in the published work and should be placed in a new section before the references list. An example:

  • Title of new section: Declaration of generative AI and AI-assisted technologies in the writing process.
  • Statement: During the preparation of this work the author(s) used [NAME TOOL / SERVICE] in order to [REASON]. After using this tool/service, the author(s) reviewed and edited the content as needed and take(s) full responsibility for the content of the published article.

The declaration does not apply to the use of basic tools, such as tools used to check grammar, spelling and references. 

Please note: to protect authors’ rights and the confidentiality of their research, this journal does not currently allow the use of generative AI or AI-assisted technologies such as ChatGPT or similar services by reviewers or editors in the peer review and manuscript evaluation process. We are actively evaluating compliant AI tools and may revise this policy in the future.

Writing and formatting File format

We ask you to provide editable source files for your entire submission (including figures, tables and text graphics). Some guidelines:

  • Save files in an editable format, using the extension .doc/.docx for Word files and .tex for LaTeX files. A PDF is not an acceptable source file.
  • Lay out text in a single-column format.
  • Use spell-check and grammar-check functions to avoid errors.
Manuscript Formatting

To ensure that your manuscript meets the journal’s formatting and structural requirements, please download and carefully follow the Manuscript Template. This template provides comprehensive guidelines on document structure, font styles, citation formatting, figure and table presentation, and other essential elements. Adhering to these guidelines will facilitate the review process and improve the efficiency of manuscript handling.

Before submission, please ensure that:

  • The manuscript follows the required formatting, including title page specifications, reference style, and section organization.
  • No author-related information is included in the main manuscript file to maintain anonymity in peer review.
  • Figures and tables are formatted correctly and submitted in the appropriate file types.

Using this template will help streamline the editorial and review process while ensuring consistency across published articles.

Submitting your manuscript

Before completing the submission of your manuscript, we advise you to read our submission checklist:

  • One author has been designated as the corresponding author and their full contact details (email address, full postal address and phone numbers) have been provided.
  • All files have been uploaded, including keywords, figure captions and tables (including a title, description and footnotes) included.
  • Spelling and grammar checks have been carried out.
  • All references in the article text are cited in the reference list and vice versa.
  • Permission has been obtained for the use of any copyrighted material from other sources, including the Web.
  • All authors understand that they are responsible for payment of the article publishing charge (APC) if the manuscript is accepted. Payment of the APC may be covered by the corresponding author’s institution, or the research funder.